Atlas Trials

Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices

Clinical trial NCT02508623 · UNKNOWN

Trial details

NCT number
NCT02508623
Sponsor
University of Padova
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Liver CirrhosisPortal Hypertension
Start date
2015-07-01
Primary completion
2017-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.